Boothbay Fund Management’s Globus Medical GMED Stock Holding History

Boothbay Fund Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$266K	Sell	3,362 -2,997	-47%	-$255K	﹤0.01%	1790
2026 Q1	$548K	Buy	+6,359	New	+$571K	0.01%	1291
2025 Q3	–	Sell	-4,783	Closed	-$282K	–	1974
2025 Q2	$282K	Buy	+4,783	New	+$309K	0.01%	1129
2025 Q1	–	Sell	-27,896	Closed	-$2.31M	–	1546
2024 Q4	$2.31M	Sell	27,896 -142,371	-84%	-$11.2M	0.06%	413
2024 Q3	$12.2M	Sell	170,267 -34,234	-17%	-$2.42M	0.28%	57
2024 Q2	$14M	Sell	204,501 -46,889	-19%	-$2.8M	0.33%	41
2024 Q1	$13.5M	Buy	251,390 +159,228	+173%	+$8.56M	0.26%	51
2023 Q4	$4.91M	Buy	92,162 +79,990	+657%	+$3.9M	0.13%	202
2023 Q3	$604K	Buy	+12,172	New	+$681K	0.01%	958
2022 Q4	–	Sell	-3,428	Closed	-$204K	–	2157
2022 Q3	$204K	Sell	3,428 -1,057	-24%	-$63.7K	0.01%	1836
2022 Q2	$252K	Buy	+4,485	New	+$295K	0.01%	1575

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Boothbay Fund Management's GMED Position: Q2 2026 in Review

Boothbay Fund Management reduced its Globus Medical (GMED) stake by 47% in Q2 2026, selling an estimated $255K and leaving 3,362 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #1790.

Boothbay Fund Management first reported a position in GMED in Q2 2022 and has held it in 11 quarters since. The position peaked at $14M in Q2 2024. 597 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Boothbay Fund Management held 3,362 shares of Globus Medical worth $266K as of Q2 2026.
Boothbay Fund Management sold 2,997 Globus Medical shares in Q2 2026, an estimated $255K.
Globus Medical made up ﹤0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1790 holding.
Boothbay Fund Management first reported a position in Globus Medical in Q2 2022 and has held it in 11 quarters since.
Boothbay Fund Management's Globus Medical position peaked at $14M in Q2 2024.
597 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.